Cart
sales@molnova.com
Zandelisib
CAS No. 1401436-95-0
Zandelisib( ME-401 | PWT-143 )
Catalog No. M26519 CAS No. 1401436-95-0
Zandelisib is an inhibitor of phosphatidylinositol 3-kinase (PI3K)(p110δ, IC50 of 3.5 nM), and with antineoplastic activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 285 | Get Quote |
|
| 10MG | 475 | Get Quote |
|
| 25MG | 770 | Get Quote |
|
| 50MG | 1062 | Get Quote |
|
| 100MG | 1431 | Get Quote |
|
| 500MG | 2862 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameZandelisib
-
NoteResearch use only, not for human use.
-
Brief DescriptionZandelisib is an inhibitor of phosphatidylinositol 3-kinase (PI3K)(p110δ, IC50 of 3.5 nM), and with antineoplastic activity.
-
DescriptionZandelisib is an inhibitor of phosphatidylinositol 3-kinase (PI3K)(p110δ, IC50 of 3.5 nM), and with antineoplastic activity.(In Vitro):Zandelisib inhibits PI3Ks(p110α, p110β, p110γ and p110δ with IC50s of 4, 976 nM, 605 nM, 817 nM and 3.5 nM, respectivey).
-
In Vitro——
-
In Vivo——
-
SynonymsME-401 | PWT-143
-
PathwayPI3K/Akt/mTOR signaling
-
TargetPI3K
-
RecptorApoptosis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1401436-95-0
-
Formula Weight576.697
-
Molecular FormulaC31H38F2N8O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 33.33 mg/mL (57.80 mM)
-
SMILESCN1CCC(CC1)c1ccccc1CC(C)(C)Nc1nc(nc(n1)-n1c(nc2ccccc12)C(F)F)N1CCOCC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Llado V, et al. Minerval induces apoptosis in Jurkat and other cancer cells. J Cell Mol Med. 2010 Mar;14(3):659-70.
molnova catalog
related products
-
SRX3207
SRX3207 is an inhibitor of Syk and PI3K and relieves tumor immunosuppression.
-
AS-041164
AS-041164 is a selective and orally active PI3Kγ isoform inhibitor(IC50 of 70 nM), and shows less activity against PI3Kα, PI3Kβ, and PI3Kδ (IC50s of 240 nM, 1.45 μM, and 1.70 μM, respectively).
-
mTOR inhibitor 9d
mTOR inhibitor 9d is a dual inhibitor of the protein kinases mTOR and PI3K with an mTOR IC50 value of 0.31 nm, and can be used for the treatment of leukemia, skin cancer, breast cancer, lung cancer and colon cancer.
